Stay updated on Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.

Latest updates to the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedNew revision entry (v3.3.2) is added to the history and the previous revision (v3.2.0) is removed, reflecting a site-level update; this does not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the notice about government funding status on the page, with no changes to study data, recruitment status, or other core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check58 days agoChange DetectedThe new screenshot shows updates to the Study Status and Recruitment Status sections on the history page, along with related changes in the list of daily version records and locations.SummaryDifference0.1%

- Check87 days agoChange DetectedSignificant update: adds a government funding lapse notice and operating status information, plus a version bump to v3.2.0; removes the previous v3.1.0 tag.SummaryDifference12%

- Check94 days agoChange DetectedUpdated the revision from v3.0.2 to v3.1.0, marking a version upgrade that likely accompanies feature or fix updates.SummaryDifference0.3%

Stay in the know with updates to Comparing Crenolanib vs Midostaurin in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Crenolanib vs Midostaurin in AML Clinical Trial page.